tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

INKT Stock Latest News

MiNK Therapeutics presents data on iNKT cell therapy programs
The FlyMiNK Therapeutics presents data on iNKT cell therapy programs
3d ago
INKT
MiNK Therapeutics Appoints Dr. Robert Kadlec to Board
PremiumCompany Announcements
MiNK Therapeutics Appoints Dr. Robert Kadlec to Board
10d ago
8K
INKT
MiNK Therapeutics appoints Robert Kadlec to board of directors
PremiumThe Fly
MiNK Therapeutics appoints Robert Kadlec to board of directors
10d ago
INKT
MiNK Therapeutics, Autonomous Therapeutics enter research collaboration
PremiumThe Fly
MiNK Therapeutics, Autonomous Therapeutics enter research collaboration
1M ago
INKT
MiNK Therapeutics files to sell 4.64M shares of common stock for holders
PremiumThe Fly
MiNK Therapeutics files to sell 4.64M shares of common stock for holders
3M ago
INKT
MiNK Therapeutics reports Q2 EPS (7c), consensus (10c)
PremiumThe FlyMiNK Therapeutics reports Q2 EPS (7c), consensus (10c)
3M ago
INKT
Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
3M ago
INKT
MiNK Therapeutics regains compliance with nasdaq MVLS requirement
Premium
The Fly
MiNK Therapeutics regains compliance with nasdaq MVLS requirement
3M ago
INKT
MiNK Therapeutics presents data on agenT-797 at ATS meeting
PremiumThe Fly
MiNK Therapeutics presents data on agenT-797 at ATS meeting
6M ago
INKT
MiNK Therapeutics reports Q1 EPS (11c), consensus (15c)
PremiumThe Fly
MiNK Therapeutics reports Q1 EPS (11c), consensus (15c)
6M ago
INKT
MiNK Therapeutics appoints Yekaterina Chudnovsky as board observer
PremiumThe Fly
MiNK Therapeutics appoints Yekaterina Chudnovsky as board observer
6M ago
INKT
MiNK Therapeutics to sell 4.64M shares at $1.25 in private placement
PremiumThe Fly
MiNK Therapeutics to sell 4.64M shares at $1.25 in private placement
6M ago
INKT
MiNK announces presentation of MiNK-215 data at AACR meeting
PremiumThe FlyMiNK announces presentation of MiNK-215 data at AACR meeting
7M ago
INKT
MiNK Therapeutics reports Q4 EPS (16c), consensus (15c)
Premium
The Fly
MiNK Therapeutics reports Q4 EPS (16c), consensus (15c)
8M ago
INKT
INKT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
8M ago
INKT
MiNK Therapeutics announces preclinical data from MiNK-215
PremiumThe Fly
MiNK Therapeutics announces preclinical data from MiNK-215
8M ago
INKT
MiNK Therapeutics Strikes Convertible Note Deal with Agenus
PremiumCompany Announcements
MiNK Therapeutics Strikes Convertible Note Deal with Agenus
9M ago
8K
INKT
MiNK Therapeutics announces first patient dosed in Phase 2 study for agenT-797
PremiumThe Fly
MiNK Therapeutics announces first patient dosed in Phase 2 study for agenT-797
9M ago
INKT
MiNK announces publication of results from Phase 1/2 study of agenT-797
PremiumThe Fly
MiNK announces publication of results from Phase 1/2 study of agenT-797
9M ago
INKT
MiNK Therapeutics announces publication of case report on agenT-797
PremiumThe FlyMiNK Therapeutics announces publication of case report on agenT-797
9M ago
INKT
MiNK, ImmunoScape collaborate to discover, develop next-gen TCR therapies
Premium
The Fly
MiNK, ImmunoScape collaborate to discover, develop next-gen TCR therapies
11M ago
INKT
MiNK Therapeutics reports Q3 EPS (15c), consensus (18c)
Premium
The Fly
MiNK Therapeutics reports Q3 EPS (15c), consensus (18c)
1y ago
INKT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >